Terms: = Endocrine gland cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
394 results:
1. HER2-low and Overexpression in Mucinous Ovarian cancer: Analysis of ASCO/cap and ToGA Immunohistochemical Scoring.
Han R; Madariaga A; Gonzalez-Ochoa E; Smith AC; Wang L; Lheureux S; Rouzbahman M
Int J Gynecol Pathol; 2024 May; 43(3):275-283. PubMed ID: 38436360
[TBL] [Abstract] [Full Text] [Related]
2. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
[TBL] [Abstract] [Full Text] [Related]
3. SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells.
Yan J; Wang M; Lv S; Chen D; Wu Z; Zhou D; Zhang S; Lv J; Xu K; Xu C; Wei Y
J Control Release; 2024 Mar; 367():620-636. PubMed ID: 38311244
[TBL] [Abstract] [Full Text] [Related]
4. Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.
Bauer N; Balourdas DI; Schneider JR; Zhang X; Berger LM; Berger BT; Schwalm MP; Klopp NA; Siveke JT; Knapp S; Joerger AC
ACS Chem Biol; 2024 Feb; 19(2):266-279. PubMed ID: 38291964
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract] [Full Text] [Related]
6. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF; Hinterleitner C; Kiefer LS; Singer S; Mattern S; Schwenck J; Reischl G; Sipos B; Lauer UM; Dittmann H; Zender L; la Fougère C; Hinterleitner M
Clin Nucl Med; 2024 Mar; 49(3):207-214. PubMed ID: 38271237
[TBL] [Abstract] [Full Text] [Related]
7. CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma.
Zhang Y; Yu R; Zhao C; Liang J; Zhang Y; Su H; Zhao J; Wu H; Xu S; Zhang Z; Wang L; Zou X; Zhu Y; Zhang S; Lv Y
Adv Sci (Weinh); 2024 Jan; 11(1):e2305279. PubMed ID: 37968249
[TBL] [Abstract] [Full Text] [Related]
8. Coinhibition of topoisomerase 1 and brd4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.
Cameron DP; Grosser J; Ladigan S; Kuzin V; Iliopoulou E; Wiegard A; Benredjem H; Jackson K; Liffers ST; Lueong S; Cheung PF; Vangala D; Pohl M; Viebahn R; Teschendorf C; Wolters H; Usta S; Geng K; Kutter C; Arsenian-Henriksson M; Siveke JT; Tannapfel A; Schmiegel W; Hahn SA; Baranello L
Sci Adv; 2023 Oct; 9(41):eadg5109. PubMed ID: 37831776
[TBL] [Abstract] [Full Text] [Related]
9. Methylation of brd4 by PRMT1 regulates brd4 phosphorylation and promotes ovarian cancer invasion.
Liu Y; Liu H; Ye M; Jiang M; Chen X; Song G; Ji H; Wang ZW; Zhu X
Cell Death Dis; 2023 Sep; 14(9):624. PubMed ID: 37737256
[TBL] [Abstract] [Full Text] [Related]
10. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
11. Arterial events in cancer patients treated with apixaban for venous thrombosis.
Larsen TL; Svalastoga M; Brekke J; Enden T; Frøen H; Garresori H; Jacobsen EM; Paulsen PQ; Porojnicu AC; Ree AH; Torfoss D; Velle EO; Wik HS; Ghanima W; Sandset PM; Dahm AEA
Thromb Res; 2023 Aug; 228():128-133. PubMed ID: 37327527
[TBL] [Abstract] [Full Text] [Related]
12. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
Wilson GC; Patel SH; Wang J; Xu K; Turner KM; Becker KA; Carpinteiro A; Szabo I; Ahmad SA; Gulbins E
J Mol Med (Berl); 2023 Jul; 101(7):891-903. PubMed ID: 37246980
[TBL] [Abstract] [Full Text] [Related]
13. Pathologic Tumor Regression is Associated With Improved Survival in Pancreatic cancer.
Nicolais LM; Caron M; Verdini N; Fitzgerald TL
Am Surg; 2023 Sep; 89(9):3778-3783. PubMed ID: 37227766
[TBL] [Abstract] [Full Text] [Related]
14. YAP/brd4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
[TBL] [Abstract] [Full Text] [Related]
15. Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
Quintela M; James DW; Pociute A; Powell L; Edwards K; Coombes Z; Garcia J; Garton N; Das N; Lutchman-Singh K; Margarit L; Beynon AL; Rioja I; Prinjha RK; Harker NR; Gonzalez D; Conlan RS; Francis LW
Clin Epigenetics; 2023 Apr; 15(1):63. PubMed ID: 37060086
[TBL] [Abstract] [Full Text] [Related]
16. Oleic acid stimulates cell proliferation and brd4-L-MYC-dependent glucose transporter transcription through PPARα activation in ovarian cancer cells.
Kado T; Kusakari N; Tamaki T; Murota K; Tsujiuchi T; Fukushima N
Biochem Biophys Res Commun; 2023 May; 657():24-34. PubMed ID: 36965420
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma.
Bao QR; Frigerio I; Tripepi M; Marletta S; Martignoni G; Giardino A; Regi P; Scopelliti F; Allegrini V; Girelli R; Pucciarelli S; Spolverato G; Butturini G
Pancreatology; 2023 Apr; 23(3):266-274. PubMed ID: 36841686
[TBL] [Abstract] [Full Text] [Related]
18. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
[TBL] [Abstract] [Full Text] [Related]
19. Synergistic effect of PARP inhibitor and brd4 inhibitor in multiple models of ovarian cancer.
Huang Y; Liu C; You L; Li X; Chen G; Fan J
J Cell Mol Med; 2023 Mar; 27(5):634-649. PubMed ID: 36753396
[TBL] [Abstract] [Full Text] [Related]
20. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.
Sohn AJ; Taherian M; Katz MHG; Prakash LR; Chatterjee D; Wang H; Kim M; Tzeng CD; Lee JE; Ikoma N; Rashid A; Wolff RA; Zhao D; Koay EJ; Sun R; Maitra A; Wang H
Am J Surg Pathol; 2023 Apr; 47(4):421-430. PubMed ID: 36746143
[TBL] [Abstract] [Full Text] [Related]
[Next]
